Specify a stock or a cryptocurrency in the search bar to get a summary
Genomma Lab Internacional S.A.B. de C.V
GEKAGenomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico. Address: Av. Antonio Dovalí Jaime, number 70, Mexico City, DF, Mexico, 01210
Analytics
WallStreet Target Price
22.31 EURP/E ratio
24.2Dividend Yield
3.41 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures GEKA
Dividend Analytics GEKA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
62 %Dividend History GEKA
Stock Valuation GEKA
Financials GEKA
Results | 2019 | Dynamics |